Effectiveness of EMDR for adolescents with Major Depressive Disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28950

Enrollment

Registered

2020-10-30

Start date

2020-11-02

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

Participants in the EMDR intervention group receive EMDR treatment during six weeks (six sessions). Participant in the waiting list condition receive EMDR treatment during six weeks after a waiting ti

Psychosocial intervention

Eligibility

Age

12 Years to 17 Years

Inclusion criteria

Inclusion criteria: (a) age 12-18 years (b) Major Depressive Disorder (MDD) as primary classification (DSM-5) (c) identified memories of at least one distressing or traumatic event related to the depressive symptomatology

Exclusion criteria

Exclusion criteria: (a) suicidal attempt or serious non-suicidal self-injury requiring hospitalization in the past month (b) substance dependence

Design outcomes

Primary

Measure	Time frame
Main parameter will be the effect of EMDR treatment on depressive symptomatology. Depressive symptoms will be measured by the CDI-2 and K-SADS-PL-5.	—

Secondary

Measure	Time frame
Secondary parameters focus on the effect of EMDR treatment on comorbid PTSD, anxiety, somatic symptoms and overall social-emotional problems, measured by CATS, SCARED and SDQ. We will examine whether baseline posttraumatic stress symptoms severity, family functioning (measured by the FAD) and having experienced emotional abuse or neglect (CTQ) significantly predicts post-treatment outcome.	—

Contacts

Public ContactCorine Paauw

GGZ Rivierduinen

C.paauw@rivierduinen.nl071-8908888

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)